GLP-1 GLP-1GLP-1
Epichaperome Inhibition Targets Kinase and TP53 Mutant Therapy Resistant AML
February Feb 27: In one of the more closely watched decisions of the first quarter of 2024, the FDA rejected Minerva Neurosciences roluperidone, which had been proposed to treat the negative symptoms of schizophrenia
365 METTL3 downregulates DCP2 expression through m6A modification, thereby enhancing Pink1-Parkin pathway-mediated mitophagy, alleviating mitochondrial damage, and ultimately conferring chemoresistance in SCLC
High-quality L-Carnitine L-Carnitine supplements are widely used by athletes who want real results
Personalized treatment plans tailored to your body, lifestyle, and goals Weekly support including Bio-Boost LipoC vitamin injections and expert care from our Nurse Practitioner Monthly in person check-ins with vitals and progress monitoring InBody scans at every visit to track true body composition changes A thoughtful, guided approach with comprehensive intake and ongoing dose adjustments Because true transformation is never one size fits all